- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Horizon Pharma Plc+ Add to Watchlist
HZNP:US20.9650 USD 0.4550 2.22%
As of 20:10:00 ET on 03/03/2015.
Company Profile for Horizon Pharma Plc (HZNP)
Horizon Pharma Plc is a holding company. The Company, through its subsidiaries, develops and commercializes late-stage biopharmaceutical therapies for the treatment of pain and inflammation.
Horizon Pharma Plc
Key Executives for Horizon Pharma Plc (HZNP)
|Timothy P WalbertChairman/President/CEO||Paul W HoelscherExec VP/CFO/Secretary|
|John J KodyExec VP/Chief Commercial Ofcr||Robert F Carey "Bob"Exec VP/Chief Business Officer|
|Barry J MozeExec VP:Corporate Development||Jeffrey W ShermanExec VP:Research & Development|
|Elizabeth M HigashiVP:Investor Relations|